2013
DOI: 10.1007/s11060-013-1129-z
|View full text |Cite
|
Sign up to set email alerts
|

Valproic acid and its inhibition of tumor growth in systemic malignancies: beyond gliomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…In this regard, VPA exhibits some pharmacodynamic properties, that are unrelated to the antiepileptic activity, and preclinical studies have reported that the drug could affect tumor cells in many respects (inhibition of proliferation and angiogenesis, promotion of apoptosis and autophagy) [6]; however, the mode of action of VPA is enigmatic, and the effects on glioma cells are somewhat contradictory [7][8].…”
mentioning
confidence: 99%
“…In this regard, VPA exhibits some pharmacodynamic properties, that are unrelated to the antiepileptic activity, and preclinical studies have reported that the drug could affect tumor cells in many respects (inhibition of proliferation and angiogenesis, promotion of apoptosis and autophagy) [6]; however, the mode of action of VPA is enigmatic, and the effects on glioma cells are somewhat contradictory [7][8].…”
mentioning
confidence: 99%